My previous post pastes the stuff that's new plus
Post# of 148268
Kazempour has argued that he submitted a partially completed application to the FDA under pressure from Pourhassan. He is also trying to get his indictment dismissed on grounds that it fails to allege he was a knowing participant in a fraud.
Pourhassan counters that Kazempour, in fact, signed off on CytoDyn’s press releases, including one saying that the submission was complete.
Previous post with other stuff from article:
https://investorshangout.com/post/view?id=6621015